HONOR clinches the top spot among smartphone brands in IDC’s latest study, with a notable 17% share and a phenomenal 123.3% Year-over-Year shipments surge in Q1, 2024.
Following reports that the clinical trial of Sinovac vaccine in Brazil was halted, DOH Usec. Maria Rosario Vergeire says that they will have to evaluate first the report before stopping PH's clinical trial.